Molecular basis of human essential hypertension.

Authors

  • Sadiqa Syed
  • Masood A Qureshi

Keywords:

Genome, locus, hypertension, candidate genes

Abstract

Essential hypertension (HTN) affects over one billion people worldwide. It is a complex, multifactorial, quantitative trait under polygenic control resulting from inheritance of a number of susceptibility genes and involves multiple environmental determinants in different combinations in different individuals. The completion of the draft sequence of human genome and recent advances in the genetics have resulted in identification and characterization of various genetic mechanisms that associate increased blood pressure and cardiovascular risk factors. The possible molecular mechanisms involved in homeostasis, ranging from locally acting vasoactive peptides to components of rennin angiotensin aldosterone system to epithelial sodium channels and sodium chloride transporters have been discussed. Several vasoregulatory systems including sympathetic vasoregulation and cytokines release have been studied extensively. Despite all these efforts of identification of numerous candidate genes in different ethnic populations using different approaches and technologies, the results are still inconsistent and the genetic and molecular basis of HTN remains unclear. In view of rapid availability of useful data on various aspects of Physiology and genetics of HTN, it is pertinent to review such information focusing on association of well known candidate genes with various facets of HTN and their physiological regulatory processes. Thus HTN related risk factors, known to have interactions with genes are highlighted in this article.

References

Vasam RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged men and women; The Framingham Heart Study. JAMA 2002; 287 :1003-10

Chobanian M, The 7th Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure JAMA 2003; 289: 2562-74.

Gong M, Hubner M. Molecular genetics of human hypertension Clin Sci 2006; 110: 315-26.

Kearney PM, Whelton M, Reynold K et al. Global Burden of Hypertension: analysis of worldwide data Lancer 2005; 365-217-23

Kotlikoff M, Hall I Hypertension: Beta testing. J Clin Invest 2003; 112: 654-6.

Marteau JB, Zaiou M, Siest G et al. Genetic determinants of blood pressure regulation. J Hypertens 2005; 23: 2127-43

Hubner N, Yagil C, Yagil Y. Novel integrative approaches to the identification of candidate genes in hypertension. Hypertension 2006;47:1-5.

Zanchetti A. The basic importance of the physiological approach in clinical medicine: the experience in the area of hypertension. Arch Ital Biol 2005;143:97-102.

Coy V. Genetis of essential hypertension. J Am Aad Nure Pract 2005; 17: 219-24.

Tetsuro M. Advanced genomic analysis for hypertension. Tanpukushitsu Kakusan Koso 2005;50:2090-6

Mondry A, Loh M, Liu P et al. Polymorphism of the insertion/deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data. BMC Nephrology 2005;6:1

Kobashi G. Genetic and environmental factors associated with the development of hypertension in pregnancy. J Epidemiol 2006;16: 1-8

Luft FC. Present status of genetic mechanisms in hypertension. Med Clin North Am 2004; 88:1-18.

Meneton P, Jeunemaitre X, de-Wardener HE et al. Links between dietary salt intake, renal salt handling, blood pressure and cardiovascular disease. Physiol Rev 2005; 85: 679-715.

Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000;52:639-72

Luft FC. Mendalian forms of human hypertension and mechanisms of disease. Clin Med Res 2003;52:639-72.

Munroe PB, Wallace C, Xue MZ, et al. Increased support for linkage of a novel locus on chromosome 5q13 for essential hypertension in the British Genetics of Hypertension Study. Hypertension 2006; 48:105-11.

Von Wowern F, Bengtsson K, Lindgren CM, et al. A genome-wide scan fr early onset primary hypertension in Scandinavians. Hum Mol Genet 2003; 12: 2077-81

McBride MW, Grahem D, Delles C, et al. Functional genomics in hypertension. Curr Opin Nephro Hypertens, 2006;15: 145-51.

Rice T, Cooper RS, Wu X et al Meta analysis of genome-wide scan for blood pressure in African American an Nigerian samples. The National Heart Lung and Blood Institute Gene Link Project. Am J Hypertens, 2006;19:270-4.

Zhu DL, Wang HY, Xiong MM, Et al. Linkage of hypertension to chromosome 2q14-q23 in Chiinese families. J Hypertension 2001; 19:56-61.

Tiago AD, Badenhorst D, Nkeh B et al. Impact of renin-angiotensin aldosterone system gene variants on the severity of hypertension in patients with newly diagnosed hypertension. Am J Hypertens 2003;16:1006-10.

Cooper DN, Nussbaum RL, Krawczak M. Proposed guidelines for papers describing DNA polymorphism disease association. Human Genet 2002;110:207-8.

Mein CA, Caulfield MJ, Dobson RJ, et al. Genetics of essential hypertension. Hum Mol Genet 2004;13:R169-75

Downloads

Published

2011-12-02

How to Cite

Syed, S. ., & Qureshi, M. A. . (2011). Molecular basis of human essential hypertension. Journal of Bahria University Medical and Dental College, 1(2), 49–52. Retrieved from https://jbumdc.bahria.edu.pk/index.php/ojs/article/view/20

Issue

Vol. 1 No. 2 (2011): Volume 1 Issue 2

Section

Original Articles

License

Copyright (c) 2011 Sadiqa Syed, Masood A Qureshi

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0